undefined

undefined

Home page

Jiudian Pharmaceuticals Launches Lidocaine Gel Patch, China’s First Topical First-Line Treatment for Postherpetic Neuralgia

Jiudian Pharmaceuticals Launches Lidocaine Gel Patch, China’s First Topical First-Line Treatment for Postherpetic Neuralgia

Recently, the lidocaine gel patch developed by Jiudian Pharmaceuticals has been approved for market by the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) and has passed the generic drug quality and efficacy consistency evaluation. As a Class B national medical insurance drug, this lidocaine cataplasm is the only first-line topical medication for postherpetic neuralgia (PHN) in China, offering patients a safer, more convenient, and highly effective analgesic option.

22

2025

/

05

Jiudian Pharmaceuticals' Dexketoprofen Trometamol Tablets Approved as New Anti-inflammatory and Analgesic Option

Jiudian Pharmaceuticals' Dexketoprofen Trometamol Tablets Approved as New Anti-inflammatory and Analgesic Option

Jiudian Pharmaceuticals recently announced that its dexketoprofen trometamol tablets have received marketing approval from China's National Medical Products Administration (NMPA). The product has become China's exclusive offering to pass generic drug quality and efficacy consistency evaluation.

09

2025

/

05

Jiudian Hongyang’s API, Trazodone Hydrochloride, Approved for Market

Jiudian Hongyang’s API, Trazodone Hydrochloride, Approved for Market

Recently, Jiudian Hongyang's active pharmaceutical ingredient, Trazodone Hydrochloride (Y20230001003), has recently been approval by the National Medical Products Administration (NMPA) and successfully passed the review process.

30

2025

/

04

Jiudian Hongyang’s Pharmaceutical Excipient, Sodium Hydrogen Phosphate Heptahydrate, Approved for Market, Filling a Domestic Market Gap

Jiudian Hongyang’s Pharmaceutical Excipient, Sodium Hydrogen Phosphate Heptahydrate, Approved for Market, Filling a Domestic Market Gap

Good news! Jiudian Hongyang’s pharmaceutical excipient, Sodium Hydrogen Phosphate Heptahydrate (F20210000322), has recently been approval by the National Medical Products Administration (NMPA). Its registration status has successfully transitioned from "I" to "A," making it the first product of its kind. This will provide crucial support for the research and development, as well as the production, of pharmaceutical formulations.

27

2025

/

04

Jiudian Pharmaceutical’s Nicorandil Tablets Approved for Market

Jiudian Pharmaceutical’s Nicorandil Tablets Approved for Market

Good news! After review by the National Medical Products Administration (NMPA), Jiudian Pharmaceutical’s Nicorandil Tablets have been approved for market, and have simultaneously passed the consistency evaluation of generic drug quality and efficacy. As a dual-listed product in both the National Essential Drug List and the Class A Reimbursable Drug List, this medication offers patients a new option with superior efficacy and safety, thanks to its unique dual-action mechanism and significant clinical benefits.

24

2025

/

04

JiuDian Hongyang Shines at Expofarma in Mexico

JiuDian Hongyang Shines at Expofarma in Mexico

Recently, Jiudian Hongyang’s International Expansion Department made a remarkable appearance at the Expofarma, held at the World Trade Center in Mexico City.

17

2025

/

04

Jiudian Pharmaceutical Showcases Innovative Achievements at CPHI Japan

Jiudian Pharmaceutical Showcases Innovative Achievements at CPHI Japan

From April 9 to 11, 2025, the CPHI Japan Pharmaceutical Ingredients Exhibition was grandly held at the Tokyo International Exhibition Center. As one of the most influential events in the pharmaceutical industry in Asia, this year’s exhibition covered an area of 26,000 square meters and attracted over 650 exhibitors from around the world. The event spanned the entire pharmaceutical industry chain, from active pharmaceutical ingredients (APIs) and biologics to intelligent pharmaceutical equipment, drawing more than 25,000 professional visitors for networking and discussions.

16

2025

/

04

Running for Health, Enjoying Movement – JiuDian Pharmaceutical Sponsors the Shanghai Maqiao Half Marathon

Running for Health, Enjoying Movement – JiuDian Pharmaceutical Sponsors the Shanghai Maqiao Half Marathon

On the morning of April 12 at 8:00 AM, the “Shanghai Bank Cup · 2025 Shanghai Maqiao International Half Marathon” organized by the People's Government of Minhang District, Shanghai, officially started at the Jiushi Sports Qizhong Tennis Center. As one of the event sponsors, Jiudian Pharmaceutical joined partners such as Shanghai Bank and Qingdao Beerin supporting this sports extravaganza that blends athletic passion with urban culture, showcasing corporate responsibility and promoting the concept of a healthy lifestyle.

14

2025

/

04

< 1 2 3 4...9 >

Bldg A1, Wukuang Lugu Science and Technology Industry Park, No.28 Lutian Road, Hi-tech development zone, Changsha, Hunan, China TEL. 0086-731-88220222

1

Business license

SEO www.300.cn changsha Privacy policy